Brief: Repare Therapeutics To Regain Global Rights To Camonsertib

Repare Therapeutics

12/02/2024 21:58

Feb 12 (Reuters) - Repare Therapeutics Inc  RPTX.O :
    * REPARE THERAPEUTICS TO REGAIN GLOBAL RIGHTS TO CAMONSERTIB
    * REPARE THERAPEUTICS INC - REPARE WILL REGAIN CONTROL OF
ITS
POTENTIAL BEST-IN-CLASS ORAL SMALL MOLECULE ATR INHIBITOR
    * REPARE THERAPEUTICS INC - MET ALL OBLIGATIONS UNDER ROCHE
AGREEMENT TO DATE, AND RECENTLY EARNED A $40 MILLION MILESTONE
PAYMENT FROM ROCHE
    * REPARE THERAPEUTICS- SEES EXISTING CASH,CASH
EQUIVALENTS,MARKETABLE SECURITIES TO PROVIDE SUFFICIENT CAPITAL
TO FUND PLANNED OPERATIONS INTO MID-2026

Source text for Eikon:  ID:nBw2jDL2ya 
Further company coverage:  RPTX.O 

 ((reuters.briefs@thomsonreuters.com;))